Autopsy report · NCT03587519

Short Versus Long Interval to Ileostomy Reversal After Ileal Pouch Surgery

“Adverse Event”

The sponsor’s own words in the registry.

Life of this trial

• Registered 4 months before it started.
• Ran for about 2 years 5 months before it stopped.
• 36 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Na

Sponsor

University of Colorado, Denver

Sponsor type

University, hospital or other

Conditions

Ulcerative Colitis; Ileal Pouch; Ileostomy - Stoma

Interventions

Early; Late

Participants

36

Sites

8

Countries

United States

Trials that died the same way

• Safety and Bioactivity of AXT107 in Subjects With Diabetic Macular Edema
  “Adverse Events” (97% match in meaning)
• Phase I Trial of AZD1775 and Belinostat in Treating Patients With Relapsed or Refractory Myeloid Malignancies or Untreated Acute Myeloid Leukemia
  “Other - Adverse Events” (90% match in meaning)
• Ipilimumab + Androgen Depravation Therapy in Prostate Cancer
  “Due to adverse events” (85% match in meaning)
• Collagenase Clostridium Histolyticum for Refractory Iatrogenic Esophageal Strictures
  “unexpected serious adverse event” (81% match in meaning)
• Study to Evaluate the Efficacy, Safety and Immunogenicity of Subcutaneous HX575 in the Treatment of Anemia Associated With Chronic Kidney Disease (SWEEP)
  “investigation of adverse events in a related clinical study” (80% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.